Institut d'Investigació Biomèdica de Bellvitge

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.idibell.cat

Clinical Trials

Reversibility of Cardiac Conduction Disturbances Following TAVI

Not Applicable

Recruiting

Conditions: Transcatheter Aortic Valve Implantation
Aortic Stenosis
Conduction Disturbances

Interventions: Diagnostic Test: Electrophysiological study (EP study)
Diagnostic Test: ePatch (extended Holter Monitoring)

First Posted Date: 2024-07-01

Last Posted Date: 2024-07-01

Lead Sponsor: Institut d'Investigació Biomèdica de Bellvitge

Target Recruit Count: 209

Registration Number: NCT06481137

Locations: 🇪🇸
Hospital Universitari de Bellvitge, L' Hospitalet De Llobregat, Barcelona, Spain

Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy

Not Applicable

Recruiting

Conditions: Complete Heart Block
Second Degree Atrioventricular Block Möbitz Type II

Interventions: Device: Pacemaker implant

First Posted Date: 2024-06-26

Last Posted Date: 2024-07-15

Lead Sponsor: Institut d'Investigació Biomèdica de Bellvitge

Target Recruit Count: 326

Registration Number: NCT06474819

Locations: 🇪🇸
Hospital La Fe, Valencia, Spain
🇪🇸
Hospital General Universitario de Castellón, Castellón De La Plana, Spain
🇪🇸
Hospital Vall d'Hebrón, Barcelona, Spain

and more 3 locations

Integrating Molecular, Genomic, Morphology and Environmental Features to Improve Precision Diagnosis and Treatment in Interstitial Lung Diseases (PRECISION-ILD)

Recruiting

Conditions: Interstitial Lung Disease
Interstitial Fibrosis

First Posted Date: 2023-08-21

Last Posted Date: 2023-08-21

Lead Sponsor: Institut d'Investigació Biomèdica de Bellvitge

Target Recruit Count: 1000

Registration Number: NCT05998512

Locations: 🇪🇸
Hospital La Princesa, Madrid, Spain
🇪🇸
Hospital Virgen del Rocío, Sevilla, Spain
🇪🇸
Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain

Cardioinhibitory Reflex Syncope. Permanent Pacemaker Therapy or Cardioneuroablation?

Not Applicable

Recruiting

Conditions: Reflex Syncope

Interventions: Device: Permanent pacemaker therapy
Procedure: Cardioneuroablation

First Posted Date: 2023-05-11

Last Posted Date: 2024-01-25

Lead Sponsor: Institut d'Investigació Biomèdica de Bellvitge

Target Recruit Count: 90

Registration Number: NCT05855603

Locations: 🇪🇸
Hospital del Mar, Barcelona, Spain
🇪🇸
Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
🇪🇸
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

and more 7 locations

Polyphenol Supplementation and Morbid Obesity Parameters

Not Applicable

Completed

Conditions: Morbid Obesity

Interventions: Dietary Supplement: Polyphenol-rich supplement
Other: Placebo

First Posted Date: 2022-06-23

Last Posted Date: 2023-08-09

Lead Sponsor: Institut d'Investigació Biomèdica de Bellvitge

Target Recruit Count: 37

Registration Number: NCT05428540

Locations: 🇪🇸
Hospital Universitario de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain

Acceptability of Self-sampling for Cervical Cancer Screening

Not Applicable

Conditions: Cervical Cancer Screening
Self-sampling
HPV-Related Cervical Carcinoma

Interventions: Device: Explanation on how to use self-sampling device and training in the screening visit.
Other: Only explanation on how to use self-sampling device.

First Posted Date: 2022-04-07

Last Posted Date: 2022-04-14

Lead Sponsor: Institut d'Investigació Biomèdica de Bellvitge

Target Recruit Count: 1614

Registration Number: NCT05314907

Locations: 🇪🇸
Institut Català d'Oncologia, L'Hospitalet De Llobregat, Barcelona, Spain
🇪🇸
CAP II Cerdanyola-Ripollet - Institut Català de la Salut, Ripollet, Barcelona, Spain
🇪🇸
Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas De Gran Canaria, Canary Islands, Spain

Effect of Loratadine in Lymphangioleiomyomatosis

Phase 2

Conditions: Lymphangioleiomyomatosis

Interventions: Drug: Placebo 10mg/day added to rapamycin for 12 months
Drug: Loratadine

First Posted Date: 2022-01-13

Last Posted Date: 2022-01-27

Lead Sponsor: Institut d'Investigació Biomèdica de Bellvitge

Target Recruit Count: 62

Registration Number: NCT05190627

Locations: 🇪🇸
Hospital Puerta de Hierro, Madrid, Spain
🇪🇸
Hospital La Princes, Madrid, Spain
🇪🇸
Hospital Marqués de Valdecillas, Santander, Spain

and more 3 locations

Homecare Integral Support Program for IPF Patients

Not Applicable

Completed

Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Combination Product: Comprehensive patient support program (educational, physiotherapy, nutritional, emotional)

First Posted Date: 2021-12-30

Last Posted Date: 2021-12-30

Lead Sponsor: Institut d'Investigació Biomèdica de Bellvitge

Target Recruit Count: 95

Registration Number: NCT05173571

Locations: 🇪🇸
IDIBELL. University Hospital of Bellvitge, Hospitalet de Llobregat, Spain

Infectious Diseases Experts as Part of the Antibiotic Stewardship Team in Primary Care

Not Applicable

Completed

Conditions: Infectious Disease

Interventions: Behavioral: Standard AMS program
Behavioral: Advanced AMS program

First Posted Date: 2021-04-19

Last Posted Date: 2024-10-02

Lead Sponsor: Institut d'Investigació Biomèdica de Bellvitge

Target Recruit Count: 2600

Registration Number: NCT04848883

Locations: 🇪🇸
Hospital Univeristari de Bellvitge, Barcelona, Cataluña, Spain

Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19

Phase 2

Conditions: Fibrotic Pulmonary Sequelae Post-COVID19 Infection

Interventions: Drug: Placebo
Drug: Pirfenidone

First Posted Date: 2020-10-29

Last Posted Date: 2021-12-30

Lead Sponsor: Institut d'Investigació Biomèdica de Bellvitge

Target Recruit Count: 148

Registration Number: NCT04607928

Locations: 🇪🇸
Hospital Germans Trias i Pujol, Badalona, Spain
🇪🇸
University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona, Spain
🇪🇸
Hospital Clínic, Barcelona, Spain

and more 5 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy